FindTrial
Sign In

An observational cross sectional study on prevalence of ocular surface disease in patients with Glaucoma on topical Anti Glaucoma medications

Prevalence of Ocular surface Disease in patients with Glaucoma on topical Anti Glaucoma medications - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/076199
Enrollment
157
Registered
2024-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H401- Open-angle glaucoma

Interventions

Intervention1: nil: nil

Sponsors

Dr H Harshitha Yelamanchi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Glaucoma and using topical medications for atleast 6 months

Exclusion criteria

Exclusion criteria: Patients on other topical drugs with preservatives Current use of contact lenses. Presence of Pterygium Previous ocular surgeries Recent clear corneal cataract surgery in last 3 months

Design outcomes

Primary

MeasureTime frame
Assess Lipiview,Schirmers test,TBUT, and ocular surface gradingTimepoint: 6 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr. H Harshitha Yelamanchi

Sankara Eye Hospital

malleswari6372@gmail.com9493714701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026